
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1020 | 1000 | 1056 | 975 | 1326 | - |
Fund Return | 2% | -0.02% | 5.63% | -0.83% | 5.81% | - |
Place in category | 62 | 39 | 37 | 53 | 29 | - |
% in Category | 48 | 33 | 31 | 44 | 32 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 32.5B | 1.96 | 8.05 | 10.42 | ||
T. Rowe Price Blue Chip Growth | 25.43B | -0.83 | 13.21 | 14.08 | ||
T. Rowe Price Capital AppreciationI | 27.35B | 1.99 | 8.19 | - | ||
T. Rowe Price Blue Chip Growth I | 23.57B | -0.80 | 13.36 | - | ||
T. Rowe Price Instl Large Cap Growt | 18.06B | 0.04 | 13.08 | 15.45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 4.51B | 1.92 | 1.31 | 4.72 | ||
Fidelity Series International Sm C | 3.78B | 3.58 | 3.68 | 7.33 | ||
Artisan International Small Cap Ins | 3.11B | 1.49 | -0.40 | - | ||
T. Rowe Price International Discov | 1.82B | 1.99 | -0.98 | 6.62 | ||
Oppenheimer International Small-MiI | 1.82B | 3.88 | -2.87 | 6.38 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BAWAG | AT0000BAWAG2 | 2.35 | 79.900 | -3.33% | |
MercadoLibre | US58733R1023 | 1.94 | 1,809.18 | -0.93% | |
Redcare Pharmacy NV | NL0012044747 | 1.53 | 109.200 | -16.70% | |
Spie | FR0012757854 | 1.47 | 36.50 | -3.13% | |
Amplifon | IT0004056880 | 1.23 | 17.100 | -4.12% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review